Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05168930
Title Zanubrutinib + Venetoclax in CLL/SLL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jennifer R. Brown, MD, PhD
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Venetoclax + Zanubrutinib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Brigham and Women's Hospital Recruiting Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02115 United States Details
Beth Israel Deaconess Medical Center Not yet recruiting Boston Massachusetts 02215 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field